Peptide YY Activators
Peptide YY activators include a variety of chemical compounds that indirectly augment the functional activity of Peptide YY through modulation of various signaling pathways and physiological processes, especially those related to appetite control and gastrointestinal motility. Forskolin, for instance, increases intracellular cAMP levels, potentially amplifying the Peptide YY mediated effects on reducing appetite by enhancing relevant cellular signaling pathways. Capsaicin's interaction with sensory neurons suggests a possible enhancement of the Peptide YY's role in gut-brain signaling, thus influencing satiety. Similarly, substances like caffeine and nicotine, known to modulate appetite and feeding behavior, might indirectly affect the pathways regulating or regulated by Peptide YY, altering its functional impact. Oleoylethanolamide, known for its role in lipid metabolism and reducing food intake, along with Epigallocatechin gallate, a compound affecting metabolic rate and fat oxidation, could influence Peptide YY activity through shared pathways in energy homeostasis.
Additionally, compounds like naltrexone, liraglutide, and resveratrol might modulate Peptide YY's activity by influencing overlapping pathways associated with energy balance, appetite, and gut motility. Naltrexone's role in opioid receptor antagonism could affect eating behavior, potentially enhancing Peptide YY's role in appetite suppression. Liraglutide, mimicking GLP-1 effects, might synergistically or additively influence Peptide YY's activity. Resveratrol's impact on insulin sensitivity and fat metabolism offers potential cross-talk with Peptide YY pathways, indirectly modulating its effects. Lastly, Metformin and Pioglitazone, widely used in glucose metabolism management, might also affect Peptide YY indirectly through alterations in nutrient sensing and energy balance, showcasing the diverse and complex nature of potential Peptide YY activators in modulating satiety and gastrointestinal functions without direct interaction. This intricate network of indirect activators underscores the multifaceted roles and regulation of Peptide YY in maintaining energy and digestive homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can enhance the signaling pathways that Peptide YY is involved in, potentially increasing its effect on reducing appetite and slowing gastrointestinal motility. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Capsaicin interacts with sensory neurons that can influence gut-brain signaling, potentially enhancing the satiety effect mediated by Peptide YY. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine consumption influences metabolic rate and appetite control, possibly affecting Peptide YY activity indirectly through alterations in energy balance and gut motility. | ||||||
Oleylethanolamide | 111-58-0 | sc-201400 sc-201400A | 10 mg 50 mg | $90.00 $194.00 | 1 | |
OEA is known to reduce food intake and enhance lipid metabolism, potentially interacting with pathways that Peptide YY also influences, leading to enhanced activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Found in green tea, EGCG can influence metabolic rate and fat oxidation, possibly affecting signaling pathways that modulate Peptide YY's role in energy homeostasis. | ||||||
Naloxone | 465-65-6 | sc-477809 | 200 mg | $306.00 | 5 | |
As an opioid receptor antagonist, naltrexone might influence feeding behavior and energy balance, indirectly affecting Peptide YY activity. | ||||||
Liraglutide | 204656-20-2 | sc-507404 | 1 mg | $220.00 | ||
Liraglutide, a GLP-1 analog, might enhance Peptide YY release or mimic its effects due to the overlapping roles in regulating appetite and glucose homeostasis. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences insulin sensitivity and fat metabolism, pathways that Peptide YY may also affect, thus potentially enhancing its activity indirectly. | ||||||
Dextran | 9004-54-0 | sc-218165 sc-218165A sc-218165B sc-218165C sc-218165D sc-218165E | 10 g 50 g 100 g 250 g 500 g 1 kg | $73.00 $133.00 $245.00 $485.00 $765.00 $1020.00 | ||
Although it's a protein, synthetic leptin or leptin analogs might influence energy balance and appetite control mechanisms that also involve Peptide YY. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin influences glucose metabolism and might affect gut hormones including Peptide YY, indirectly influencing its activity. | ||||||